Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

116 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cyclosporine: experience with therapeutic monitoring.
Bowers LD, Canafax DM. Bowers LD, et al. Among authors: canafax dm. Ther Drug Monit. 1984;6(2):142-7. Ther Drug Monit. 1984. PMID: 6377597 Review. No abstract available.
Cyclosporine monitoring.
Burckart GJ, Canafax DM, Yee GC. Burckart GJ, et al. Among authors: canafax dm. Drug Intell Clin Pharm. 1986 Sep;20(9):649-52. doi: 10.1177/106002808602000901. Drug Intell Clin Pharm. 1986. PMID: 3530679 Review.
Cyclosporine immunosuppression.
Canafax DM, Ascher NL. Canafax DM, et al. Clin Pharm. 1983 Nov-Dec;2(6):515-24. Clin Pharm. 1983. PMID: 6360494 Review.
Cyclosporine blood level monitoring: the early posttransplant period.
Ferguson RM, Canafax DM, Sawchuck RT, Simmons RL. Ferguson RM, et al. Among authors: canafax dm. Transplant Proc. 1986 Apr;18(2 Suppl 1):113-22. Transplant Proc. 1986. PMID: 3515676 No abstract available.
Studies of cyclosporine blood levels: analysis, clinical utility, pharmacokinetics, metabolites, and chronopharmacology.
Bowers LD, Canafax DM, Singh J, Seifedlin R, Simmons RL, Najarian JS. Bowers LD, et al. Among authors: canafax dm. Transplant Proc. 1986 Dec;18(6 Suppl 5):137-43. Transplant Proc. 1986. PMID: 3787708 No abstract available.
Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression.
Cipolle RJ, Canafax DM, Rabatin J, Bowers LD, Sutherland DE, Hrushesky WJ. Cipolle RJ, et al. Among authors: canafax dm. Pharmacotherapy. 1988;8(1):47-51. doi: 10.1002/j.1875-9114.1988.tb04065.x. Pharmacotherapy. 1988. PMID: 3287355
Cyclosporine-ketoconazole: a potentially dangerous drug-drug interaction.
Shepard JH, Canafax DM, Simmons RL, Najarian JS. Shepard JH, et al. Among authors: canafax dm. Clin Pharm. 1986 Jun;5(6):468. Clin Pharm. 1986. PMID: 3720214 No abstract available.
A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE. Najarian JS, et al. Among authors: canafax dm. Ann Surg. 1985 Feb;201(2):142-57. doi: 10.1097/00000658-198502000-00003. Ann Surg. 1985. PMID: 3882063 Free PMC article. Clinical Trial.
Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients.
Lewis RL, Canafax DM, Pettit KG, DiCesare J, Kaniecki DJ, Arnold RJ, Roberts MS. Lewis RL, et al. Among authors: canafax dm. Transplant Proc. 1996 Aug;28(4):2214-7. Transplant Proc. 1996. PMID: 8769203 Clinical Trial. No abstract available.
Cyclosporine and immunosuppressive regimens in renal transplantation.
Canafax DM, Sutherland DE, Matas AJ, Payne WD, Dunn DL, Najarian JS. Canafax DM, et al. N Engl J Med. 1988 Nov 10;319(19):1287-8. doi: 10.1056/NEJM198811103191914. N Engl J Med. 1988. PMID: 3054547 No abstract available.
116 results
Jump to page